Sebo Gene Wang et al. 2024. A Case Study on First-In-Human High-Cumulative-Dose Allogeneic Mesenchymal Stem Cell therapy in Multiple Myeloma. New Visions in Medicine and Medical Science Vol. 3. (Mar. 2024), 8–15. DOI:https://doi.org/10.9734/bpi/nvmms/v3/7223B.